Vitamin D status and multiple health outcomes in females aged 16-25 years participating in a randomized controlled trial
- Research Opportunity
- Masters by Research, Honours, Master of Biomedical Science
- Project Status
- Medicine and Radiology
- Royal Melbourne Hospital
|Prof John Warkemail@example.com||8344 3258||Personal web page|
|Prof Suzanne Garland||Personal web page|
Low vitamin D levels are associated with an increased risk of numerous chronic health conditions, including poor musculoskeletal health and osteoporosis. However, few researchers have investigated these relationships in young females. We present a novel opportunity for students to investigate these associations in 16-25 year old females participating in a randomized clinical trial as part of the Safe-D study. Participants with 25 OHD levels 25 to 75 nmol/L were randomized to one of three groups in 1:1:1 ratio: a mobile phone–based application designed to encourage safe sun exposure, vitamin D supplementation (1000 IU/day), and a control group.
Data from comprehensive surveys, blood tests, bone densitometry, body composition scans, and Leonardo mechanography tests are available on participants at baseline and at 12 months post baseline. Therefore, students will also have the opportunity to determine a research project according to their own interests from this rich dataset, and investigate associations longitudinally. Findings from this study will help provide an insight into the effects of vitamin D levels on several health outcomes, including musculoskeletal health, mental health, and monitoring for skin changes. Suitable for Honours, MDRP, MBiomedSc, MPH, or Masters by Research studies.
School Research Themes
Masters by Research, Honours, Master of Biomedical Science
Graduate Research Students who are interested in joining this project will need to consider their elegibility as well as other Graduate Research requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.